EGFR and neoplasm: Co-culture of tumor and effector cells at different E/T ratios for different times indicated that anti-EGFR CAR1-T, CAR2-T, and CAR4-T cells lysed ESCC cells in a dose- and time-dependent manner (Figure 4C,D).